Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial.

LARC choice continuation contraception contraceptive-counseling long-acting reversible contraception unintended pregnancy

Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
13 Feb 2024
Historique:
revised: 18 12 2023
received: 27 09 2023
accepted: 12 01 2024
medline: 14 2 2024
pubmed: 14 2 2024
entrez: 14 2 2024
Statut: aheadofprint

Résumé

Highly effective long-acting reversible contraceptive (LARC) methods reduce unintended pregnancy rates; however, these methods are underutilized. The LOWE trial intervention provided structured contraceptive counseling resulting in increased uptake of LARC. This longitudinal follow up of the LOWE study assessed the long-term impact of the intervention by investigating the contraceptive use at 12 months with a focus on continued use of LARC. In the cluster randomized LOWE trial, abortion, youth, and maternal health clinics were randomized to provide either structured contraceptive counseling (intervention) or standard contraceptive counseling (control). The intervention consisted of an educational video on contraceptive methods, key questions asked by the health care provider, a tiered effectiveness chart and a box of contraceptive models. Women ≥ age 18, who were sexually active or planned to be in the upcoming 6 months, could participate in the study. We assessed self-reported contraceptive use at three, six and 12 months. Contraceptive choice and switches were analyzed with descriptive statistics. Contraceptive use at 12 months and continued use of LARC were analyzed using mixed logistic regressions, with clinic included as a random effect. Analysis with imputed values were performed for missing data to test the robustness of results. Overall, at 12 months, women in the intervention group were more likely to be using a LARC method (aOR 1.90, 95% CI: 1.31-2.76) and less likely to be using a short-acting reversible contraceptive (SARC) method (aOR 0.66, 95% CI: 0.46-0.93) compared to the control group. Women counseled at abortion (aOR 2.97, 95% CI: 1.36-6.75) and youth clinics (aOR 1.81, 95% CI: 1.08-3.03) were more likely to be using a LARC method, while no significant difference was seen in maternal health clinics (aOR 1.84, 95% CI: 0.96-3.66). Among women initiating LARC, continuation rates at 12 months did not differ between study groups (63.9% vs. 63.7%). The most common reasons for contraceptive discontinuation were wish for pregnancy, followed by irregular bleeding, and mood changes. The LOWE trial intervention resulted in increased LARC use also at 12 months. Strategies on how to sustain LARC use needs to be further investigated.

Identifiants

pubmed: 38351571
doi: 10.1111/aogs.14792
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Vetenskapsrådet
ID : 2021-01042
Organisme : Region Stockholm
ID : FoUI-954072
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : FORTE STYA-2016-01063 STYA-2016-01063

Informations de copyright

© 2024 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

Bearak J, Popinchalk A, Ganatra B, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019. Lancet Glob Health. 2020;8:e1152-e1161.
Kopp Kallner H, Thunell L, Brynhildsen J, Lindeberg M, Gemzell DK. Use of contraception and attitudes towards contraceptive use in Swedish women-a Nationwide survey. PLoS One. 2015;10:e0125990.
Envall N, Wallström T, Gemzell Danielsson K, Kopp KH. Use of contraception and attitudes towards contraceptive use in Swedish women: an internet-based nationwide survey. Eur J Contracept Reprod Health Care. 2022;1-9:409-417.
Hellstrom A, Danielsson KG, Kallner HK. Trends in use and attitudes towards contraception in Sweden: results of a nationwide survey. Eur J Contracept Reprod Health Care. 2019;24:154-160.
Peipert JF, Zhao QH, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105-1113.
Hogmark S, Envall N, Gemzell-Danielsson K, Kopp KH. One-year follow up of contraceptive use and pregnancy rates after early medical abortion: secondary outcomes from a randomized controlled trial of immediate post-abortion placement of intrauterine devices. Acta Obstet Gynecol Scand. 2023;102:1694-1702.
Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998-2007.
Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397-404.
Cameron ST, Glasier A, Chen ZE, Johnstone A, Dunlop C, Heller R. Effect of contraception provided at termination of pregnancy and incidence of subsequent termination of pregnancy. BJOG. 2012;119:1074-1080.
Gyllenberg F, Juselius M, Gissler M, Heikinheimo O. Long-acting reversible contraception free of charge, method initiation, and abortion rates in Finland. Am J Public Health. 2018;108:538-543.
Kilander H, Alehagen S, Svedlund L, Westlund K, Thor J, Brynhildsen J. Likelihood of repeat abortion in a Swedish cohort according to the choice of post-abortion contraception: a longitudinal study. Acta Obstet Gynecol Scand. 2016;95:565-571.
United Nations. Department of Economic and Social affairs, Population Division: Trends in Contraceptive Use Worldwide. 2015.
Peipert JF, Madden T, Allsworth JE, Secura GM. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012;120:1291-1297.
Harper CC, Rocca CH, Thompson KM, et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet. 2015;386:562-568.
Iwarsson KE, Envall N, Bizjak I, Bring J, Kallner HK, Gemzell-Danielsson K. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial). BJOG. 2021;128:1546-1554.
Envall N, Iwarsson KE, Bizjak I, Danielsson KG, Kallner HK. Evaluation of satisfaction with a model of structured contraceptive counseling: results from the LOWE trial. Acta Obstet Gynecol Scand. 2021;100:2044-2052.
Emtell Iwarsson K, Larsson EC, Bizjak I, Envall N, Kopp Kallner H, Gemzell-Danielsson K. Long-acting reversible contraception and satisfaction with structured contraceptive counselling among non-migrant, foreign-born migrant and second-generation migrant women: evidence from a cluster randomised controlled trial (the LOWE trial) in Sweden. BMJ Sex Reprod Health. 2022;48:128-136.
McNicholas C, Madden T, Secura G, Peipert JF. The contraceptive CHOICE project round up: what we did and what we learned. Clin Obstet Gynecol. 2014;57:635-643.
Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015;213(662):e1-e8.
Niemeyer Hultstrand J, Törnroos E, Tydén T, et al. Contraceptive use among women seeking an early induced abortion in Sweden. Acta Obstet Gynecol Scand. 2023;102:1496-1504.

Auteurs

Isabella Bizjak (I)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Division of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Niklas Envall (N)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences at Danderyd Hospital, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
School of Health and Welfare, Dalarna University, Falun, Sweden.

Karin Emtell Iwarsson (K)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Division of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Helena Kopp Kallner (H)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Sciences at Danderyd Hospital, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
Division of Obstetrics and Gynecology, Danderyd Hospital, Stockholm, Sweden.

Kristina Gemzell-Danielsson (K)

Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Division of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH